This document discusses syphilis, a bacterial infection caused by Treponema pallidum. It begins by describing the etiology, epidemiology, signs and symptoms, and laboratory evaluation of syphilis. It then discusses the stages of syphilis in more detail, including primary, secondary, latent, tertiary, and congenital syphilis. The stages are characterized by different clinical manifestations such as chancres, rashes, neurological symptoms, and cardiovascular involvement. The document also covers the pathology of syphilis, its transmission routes, relationship to HIV, and laboratory tests for diagnosis.
Penyakit autoimun terjadi ketika respon autoimun atau respon sistem kekebalan tubuh mengalami gangguan kemudian menyerang jaringan tubuh itu sendiri sehingga memunculkan kerusakan jaringan atau gangguan fisiologis, padahal seharusnya sistem imun hanya menyerang organisme atau zat-zat asing yang membahayakan tubuh.
Hearing the word “tumor” may naturally cause fear or panic. But a tumor is simply an abnormal buildup of tissue that occurs when cells divide too quickly or don’t die off as they normally should. A lung tumor is a tumor that occurs in the lung tissue itself or in the airways that lead to the lungs. Your airways include your:
Nose.
The inside of your nose (nasal cavity).
Throat (pharynx).
Voice box (larynx).
Windpipe (trachea).
The large tubes that carry air from your windpipe to your lungs (bronchi).
Lungs.
Lung tumors can either be cancerous (malignant) or noncancerous (benign).
If a healthcare provider tells you that you have a lung tumor and it “looks like it’s benign,” what does that mean? Should you have concerns?
When compared to malignant tumors, benign lung tumors:
Aren’t cancerous, so they won’t spread to other parts of your body.
Grow slowly or might even stop growing or shrink.
Aren’t usually life-threatening.
Usually don’t require removal.
Can expand and push against nearby tissues but won’t invade, destroy or replace other tissues.
Penyakit autoimun terjadi ketika respon autoimun atau respon sistem kekebalan tubuh mengalami gangguan kemudian menyerang jaringan tubuh itu sendiri sehingga memunculkan kerusakan jaringan atau gangguan fisiologis, padahal seharusnya sistem imun hanya menyerang organisme atau zat-zat asing yang membahayakan tubuh.
Hearing the word “tumor” may naturally cause fear or panic. But a tumor is simply an abnormal buildup of tissue that occurs when cells divide too quickly or don’t die off as they normally should. A lung tumor is a tumor that occurs in the lung tissue itself or in the airways that lead to the lungs. Your airways include your:
Nose.
The inside of your nose (nasal cavity).
Throat (pharynx).
Voice box (larynx).
Windpipe (trachea).
The large tubes that carry air from your windpipe to your lungs (bronchi).
Lungs.
Lung tumors can either be cancerous (malignant) or noncancerous (benign).
If a healthcare provider tells you that you have a lung tumor and it “looks like it’s benign,” what does that mean? Should you have concerns?
When compared to malignant tumors, benign lung tumors:
Aren’t cancerous, so they won’t spread to other parts of your body.
Grow slowly or might even stop growing or shrink.
Aren’t usually life-threatening.
Usually don’t require removal.
Can expand and push against nearby tissues but won’t invade, destroy or replace other tissues.
This PowerPoint summarizes the core points to be known on congenital(TORCH) infections. I hope you find it helpful(especially those of you who are preparing for a seminar in med school).
TORCH syndrome is a group of symptoms caused by Toxoplasmosis, Rubella, Cytomegalovirus, Herpes simplex, and other organisms including syphilis, Varicella zoster, and parvovirus.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
3. SYPHILIS
Venereal syphilis is a worldwide disease of only
humans ; there is no animal reservoir. Syphilis is
usually transmitted by sexual contact or from mother
to infant. T. pallidum may also occasionally be
transmitted as a blood‐borne infection. Untreated,
the infection follows a prolonged course, with nearly
all direct mortality arising in a relatively small
proportion of cases years after infection due to
neurological or cardiovascular complications.
Syphilis morbidity, however, includes not only the
direct impact of the disease itself, but is also amplified
by the consequences of transmission to others
(including congenital infections) and its role as a
synergistic contributor to risk for HIV acquisition. The
mortality and morbidity associated with congenital
infection are proportionally far greater than for adults
and include stillbirth, spontaneous abortion, and, for
infants surviving to birth, mental retardation and
abnormal growth and development
4. ETIOLOGY• Treponema pallidum, subspecies pallidum (SPIROCHETE)
T. pallidum - stealth pathogen (antigenic inertness)
MOTILITY
• T. pallidum is actively motile, moving with a corkscrew motion,
with bending and flexing, but with little translational movement
Resistance
• Fastidious organism that exhibits narrow optimal ranges of
• pH 7.2 to 7.4
• Temperature 30 t 37ᵒC.
• It is rapidly inactivated by mild heat (41-42ᵒC in one hour),
cold (0-4ᵒC in 1-3 days), drying and most disinfectants.
• Stored frozen at -70ᵒC in 10% glycerol or in liquid nitrogen (-130ᵒC) for 10- 15 years.
CHEMOTAXIS
• Chemotaxis machinery is thought to assist T. pallidum as it navigates throughout the body
during dissemination • Recent microarray studies indicate that a number of chemotaxis genes
are upregulated during early active syphilis infection
Two strains – Nichol’s and Reiter strains
5.
6. Epidemiology
• Syphilis is associated with significant complications if left untreated and can
facilitate the transmission and acquisition of HIV infection. Additionally,
historical data demonstrate that untreated early syphilis in pregnant
women, if acquired during the four years before delivery, can lead to
infection of the fetus in up to 80% of cases and may result in stillbirth or
death of the infant in up to 40% of cases.
• During 2000–2016, the rise in the rate of reported P&S syphilis
was primarily attributable to increased cases among men and,
specifically, among gay, bisexual, and other men who have sex with men
(collectively referred to as MSM)
7.
8.
9.
10.
11. TRANSMISSION
• Person-to-person via vaginal, anal, or oral sex through direct contact with a
syphilis chancre. Person-to-person during foreplay, even when there is no
penetrative sex (much less common)
• Blood transfusion (blood collected during early syphilis)
• Contaminated needles
• Pregnant mother with syphilis to fetus
• To hospital personnel by indiscriminate handling of infected lesions
! Syphilis infection may increase the HIV viral load of co-
infected patients, and may increase the risk of mother-to-
child transmission of HIV*
12. SYPHILIS AND HIV TRANSMISSION / ACQUISITION
How can syphilis or other STDs increase HIV transmission?
Reducing physical barriers
Increasing the number of receptor cells
Increasing HIV viral load in genital lesions, semen or
both
Genital ulcers : 3 to 11-fold increased HIV acquisition
15. Pathogenesis of Syphilis
1. Attachment invasion and Dissemination
2. Innate Host response –TLR2
3. Acquired Immunity – clinical manifestations caused by inflammatory and immune responses
rather than by any direct cytotoxic effect of T. pallidum
4. Bacterial Clearance – phagocytosis of treponemes by macrophages
Predominant cytokine – Th1
Predominant mediator – IFN-ꝩ
5. Antibodies in syphilis
6. Invasion of host immunity
and establishment of Latent infection
5. Protective and long-lasting
immunity
*very slow to develop, often
incomplete except in untreated
syphilis, and may be strain specific
16. Stage of syphilis Clinical manifestations
Primary Chancre, regional lymphadenopathy
Secondary Maculopapular rash on flank, shoulder, arm, chest, back, hands and soles of feet; malaise, headache, generalized
lymphadenopathy; less common: fever, anorexia, weight loss, mucous patches; condyloma lata; alopecia,
meningitis; myalgia; ocular complaints; hepatic, pulmonary, and neurological involvement
Latent Asymptomatic
Tertiary
Cardiovascular syphilis Aortic aneurysm, aortic valvular insufficiency, coronary artery ostial stenosis
Neurosyphilis
Acute syphilitic
meningitis
Headache, meningeal irritation, ocular involvement, cranial nerve palsies
Meningovascular Focal neurological deficits, cranial nerve palsies
General paresis Prodrome: headache, vertigo, personality disturbances, followed by acute vascular event with focal findings
Tabes dorsalis Insidious onset of dementia associated with delusional state, fatigue, intention tremors, loss of facial‐muscle tone
Lightning pains (lower extremities and abdomen most commonly), ataxia, Argyll Robertson pupil, areflexia, loss of
proprioception
Gumma Monocytic infiltrates with tissue destruction of any organ
Congenital syphilis
Early Fulminant disseminated infection, mucocutaneous lesions, osteochondritis, anaemia, hepatosplenomegaly,
neurosyphilis
Late Interstitial keratitis, lymphadenopathy, hepatosplenomegaly, bone involvement, condylomata, anaemia,
Hutchinsonian teeth, eight‐nerve deafness, recurrent arthropathy, neurosyphilis
HIV co‐infection Multiple persistent chancres; ocular involvement and neurosyphilis more common; rapid progression to gummatous
disease characterized by lesions of skin, bone, and viscera
17. SIGNS AND SYMPTOMS
Primary Syphilis
Primary lesion or "chancre" develops at the site of
inoculation. The sore usually lasts 3 to 6 weeks and
heals regardless of whether or not you receive
treatment.
• Chancre
• Progresses from macule to papule to ulcer;
• Typically painless, indurated, and has a clean base;
• Highly infectious;
• Heals spontaneously within 3 to 6 weeks; and
• Multiple lesions can occur.
• Regional lymphadenopathy: classically rubbery,
painless, bilateral
• Serologic tests for syphilis may not be positive
during early primary syphilis.
Penile Chancre
19. SECONDARY SYPHILIS
• Secondary lesions occur several weeks after the primary chancre appears;
and may persist for weeks to months.
• Primary and secondary stages may overlap
• Mucocutaneous lesions most common
• Clinical Manifestations:
• Rash (75%–100%)
• Lymphadenopathy (50%–86%)
• Malaise
• Mucous patches (6%–30%)
• Condylomata lata (10%–20%)
• Alopecia (5%)
• Liver and kidney involvement can occur
• Splenomegaly is occasionally present
• Serologic tests are usually highest in titer during this stage.
22. LATENT SYPHILIS
• Host suppresses infection, but no lesions are clinically apparent
• Only evidence is a positive serologic test
• May occur between primary and secondary stages, between
secondary relapses, and after secondary stage
• Categories:
• Early latent: <1 year duration
• Late latent: 1 year duration
23. NEUROSYPHILIS
• Occurs when T. pallidum invades the central nervous system (CNS)
• May occur at any stage of syphilis
• Can be asymptomatic
• Early neurosyphilis occurs a few months to a few years after infection
• Clinical manifestations can include acute syphilitic meningitis, meningovascular syphilis, and
ocular involvement
• Neurologic involvement can occur decades after infection and is rarely seen
• Clinical manifestations can include general paresis, tabes dorsalis, and ocular involvement
• Ocular involvement can occur in early or late neurosyphilis.
24. TERTIARY (LATE) SYPHILIS
• Approximately 30% of untreated patients progress
to the tertiary stage within 1 to 20 years.
• Rare because of the widespread availability and
use of antibiotics
• Manifestations
• Gummatous lesions
• Cardiovascular syphilis
26. CONGENITAL SYPHILIS
• Occurs when T. pallidum is transmitted from a pregnant woman to her fetus
• May lead to stillbirth, neonatal death, and infant disorders such as deafness,
neurologic impairment, and bone deformities
• Transmission can occur during any stage of syphilis; risk is much higher
during primary and secondary syphilis
• Fetal infection can occur during any trimester of pregnancy
• Wide spectrum of severity exists; only severe cases are clinically apparent at
birth
• Early lesions (most common): Infants <2 years old; usually
inflammatory
• Late lesions: Children >2 years old; tend to be immunologic and
destructive
28. LABORATORY DIAGNOSIS
4 categories
1. Direct microscopic exam (Darkfield microscopy) – used when lesions
are present
2. Non-treponemal tests- used for screening
3. Treponemal tests – for confirmatory
4. Direct antigen detection tests – used in research settings and as gold
standard for test evaluation
Aspects of Syphilis Diagnosis
1. Clinical history (History of syphilis, Known contact to an early case of syphilis, Typical signs or
symptoms of syphilis in the past 12 months,Most recent serologic test for syphilis)
2. Physical examination (Oral cavity , Lymph nodes , Skin of torso , Palms and soles , Genitalia and
perianal area, Neurologic examination, Abdomen )
3. Laboratory diagnosis
29.
30. PRINCIPLE OF VARIOUS TEST
• Tests depended upon T.pallidum demonstration by:
• Darkfield direct microscopy: Patient lesion is
abraded and fluid is taken which is seen
immediately directly under the dark field
microscope. It has a sensitivity of 80 %.
• Fluorescent microscopy: Where again the sample
is taken directly from the lesion and treated with
fluorescently labeled antibody and seen under the
fluorescent microscope.
• Non-treponemal test measure antibodies against the
cardiolipin.
• Venereal disease research laboratory (VDRL).
• Rapid plasma reagin (RPR).
• These tests become start positive after 1 to 2
weeks of infection and are positive by 4 to 6
weeks.
• Titer starts falling after the successful
treatment.
• These nontreponemal tests are negative in
the early stage of the disease, then darkfield
examination will be positive.
• ELISA
• Treponemal serologic test detect antibody to the
antigen and these are:
• Fluorescent treponemal antibody absorption (FTA-
ABS).
• Microhemagglutination treponema
Pallidum (MHA-TP).
• TPHA (Treponema pallidum hemagglutination assay) is
a treponemal antigen serologic test for syphilis.
• Tanned sheep red blood cells coated with antigen
from Nichol’s strain of Treponema pallidum are
treated with the serum of the patient.
• Sensitivity and specificity are just like FTA-ABS test.
• This test is not useful for individuals who have had
syphilis in the past.
• PCR is recommended for the neurosyphilis.
31. DARKFIELD MICROSCOPY
• What to look for
• T. pallidum morphology and motility
• Advantage
• Definitive immediate diagnosis
• Rapid results
• Disadvantages
• Requires specialized equipment and an experienced microscopist
• Possible confusion with other pathogenic and nonpathogenic spirochetes
• Must be performed immediately
• Generally not recommended on oral lesions
• Possibility of false-negatives
32. SEROLOGIC TESTS FOR SYPHILIS
• Two types
• Treponemal (qualitative)
• Nontreponemal (qualitative and quantitative)
• The use of only one type of serologic test is insufficient for
diagnosis
33. NONTREPONEMAL SEROLOGIC TESTS
• Principles
• Measure antibody directed against a cardiolipin-lecithin-cholesterol antigen
• Not specific for T. pallidum
• Titers usually correlate with disease activity and results are reported
quantitatively
• May be reactive for life, referred to as “serofast”
• Nontreponemal tests include VDRL, RPR, TRUST, USR
34. NONTREPONEMAL SEROLOGIC TESTS
(CONTINUED)
Advantages
• Rapid and inexpensive
• Easy to perform and can be done
in clinic or office
• Quantitative
• Used to follow response to
therapy
• Can be used to evaluate possible
reinfection
Disadvantages
• May be insensitive in certain
stages
• False-positive reactions may
occur
• Prozone effect may cause a
false-negative reaction (rare)
35. TREPONEMAL SEROLOGIC TESTS
• Principles
• Measure antibody directed against T. pallidum antigens
• Qualitative
• Usually reactive for life
• Titers should not be used to assess treatment response
• Treponemal tests include TP-PA, FTA-ABS, EIA, and CIA
36. SENSITIVITY OF SEROLOGICAL TESTS IN
UNTREATED SYPHILIS
Stage of Disease (Percent Positive [Range])
Test Primary Secondary Latent Tertiary
VDRL 78 (74–87) 100 95 (88–100) 71 (37–94)
RPR 86 (77–99) 100 98 (95–100) 73
FTA-ABS* 84 (70–100) 100 100 96
Treponemal
Agglutination*
76 (69–90) 100 97 (97–100) 94
EIA 93 100 100
*FTA-ABS and TP-PA are generally considered equally sensitive in the primary stage of disease.
37. CAUSES OF FALSE-POSITIVE REACTIONS IN
SEROLOGIC TESTS FOR SYPHILIS
Disease RPR/VDRL FTA-ABS TP-PA
Age Yes
Autoimmune Diseases Yes Yes
Cardiovascular Disease Yes Yes
Dermatologic Diseases Yes Yes --
Drug Abuse Yes Yes
Febrile Illness Yes
Glucosamine/chondroitin sulfate Possibly
Leprosy Yes No --
Lyme disease Yes
Malaria Yes No
Pinta, Yaws Yes Yes Yes
Recent Immunizations Yes -- --
STD other than Syphilis Yes
38. DIAGNOSIS OF LATENT SYPHILIS
• Criteria for early latent syphilis, if within the year preceding the
evaluation
• Documented seroconversion or 4-fold increase in comparison with a serologic
titer
• Unequivocal symptoms of primary or secondary syphilis reported by patient
• Contact to an infectious case of syphilis
• Only possible exposure occurred within past 12 months
• Patients with latent syphilis of unknown duration should be managed
clinically as if they have late latent syphilis.
• Public health laws require that all cases of syphilis be reported to the
state/local health department.
39. Algorithm for evaluation and
treatment of infants born to
mothers with reactive serologic
tests for syphilis.
40. ALGORITHM FOR EVALUATION AND TREATMENT OF INFANTS BORN TO MOTHERS WITH
REACTIVE SEROLOGIC TESTS FOR SYPHILIS.
41. CNS DISEASE DIAGNOSTIC ISSUES
• CNS disease can occur during any stage of syphilis.
• Conventional therapy is effective for the vast majority of immuno-competent
patients with asymptomatic CNS involvement in primary and secondary syphilis.
• Patients with syphilis who demonstrate any of the following criteria
should have a prompt CSF evaluation:
• Neurologic or ophthalmic signs or symptoms
• Evidence of active tertiary syphilis (e.g., gummatous lesions)
• Treatment failure
• HIV infection with a CD4 count ≤350 and/or a nontreponemal serologic test
titer of ≥1:32
Indications for CSF Examination
42. DIAGNOSIS OF CNS DISEASE
• No test can be used alone to diagnose neurosyphilis.
• VDRL-CSF: highly specific, but insensitive
• Diagnosis usually depends on the following factors:
• Reactive serologic test results
• Abnormalities of CSF cell count or protein
• A reactive VDRL-CSF with or without clinical manifestations
• CSF leukocyte count usually is elevated (>5 WBCs/mm3) in patients with neurosyphilis.
• The VDRL-CSF is the standard serologic test for CSF, and when reactive in the absence of
contamination of the CSF with blood, it is considered diagnostic of neurosyphilis. However,
in early syphilis it can be of unknown prognostics significance.
43. EFFECT OF HIV INFECTION ON SYPHILIS
• Syphilis and HIV infections commonly coexist.
• Clinical course is similar to non-HIV-infected patients.
• Although uncommon, unusual serologic responses can occur.
• If clinical suspicion of syphilis is high and the serologic tests are
negative, then use of other tests (e.g., biopsy of the lesion or rash)
should be considered.
• Conventional therapy is effective.
44.
45.
46. THERAPY FOR PRIMARY, SECONDARY, AND EARLY LATENT SYPHILIS
• Benzathine penicillin G 2.4 million units intramuscularly in a single dose (Bicillin L-A®)
• If penicillin allergic
• Doxycycline 100 mg orally twice daily for 14 days, or
• Tetracycline 500 mg orally 4 times daily for 14 days
THERAPY FOR LATE LATENT SYPHILIS
• Benzathine penicillin G 7.2 million units total, administered as 3 doses of 2.4 million
units intramuscularly each at 1-week intervals
• If penicillin allergic
• Doxycycline 100 mg orally twice daily for 28 days or
• Tetracycline 500 mg orally 4 times daily for 28 days
47. THERAPY FOR TERTIARY SYPHILIS
• Benzathine penicillin G 7.2 million units total, administered as 3 doses of 2.4 million
units intramuscularly each at 1-week intervals
• If penicillin allergic
• Doxycycline 100 mg orally twice daily for 28 days or
• Tetracycline 500 mg orally 4 times daily for 28 days
THERAPY FOR NEUROSYPHILIS
• Aqueous crystalline penicillin G 18–24 million units per day, administered as 3–4
million units intravenously every 4 hours or continuous infusion for 10 to14 days
intravenously
• Alternative regimen (if compliance can be ensured)
• Procaine penicillin 2.4 million units intramuscularly once daily PLUS Probenecid
500 mg orally 4 times a day, both for 10 to14 days
48. JARISCH-HERXHEIMER REACTION
• Self-limited reaction to antitreponemal therapy
• Fever, malaise, nausea/vomiting; may be associated
with chills and exacerbation of secondary rash
• Occurs within 24 hours after therapy
• Not an allergic reaction to penicillin
• More frequent after treatment with penicillin and
treatment of early syphilis
• Antipyretics can be used to manage symptoms, but they
have not been proven to prevent this reaction.
• Pregnant women should be informed of this possible
reaction, that it may precipitate early labor, and to call
obstetrician if problems develop.
49. FOLLOW-UP
• Primary or secondary syphilis
• Reexamine at 6 and 12 months.
• Follow-up titers should be
compared to the maximum or
baseline nontreponemal titer
obtained on day of treatment.
• Latent syphilis
• Reexamine at 6, 12, and 24
months.
• HIV-infected patients
• 3, 6, 9, 12 and 24 months for
primary or secondary syphilis
• 6, 12, 18, and 24 months for latent
syphilis
• Neurosyphilis
• Serologic testing as above
• Repeat CSF examination at 6-
month intervals until normal
50. TREATMENT FAILURE
• Indications of probable treatment failure or reinfection include
• Persistent or recurring clinical signs or symptoms
• Sustained 4-fold increase in titer
• Titer fails to show a 4-fold decrease within 6–12 months
• Retreat and re-evaluate for HIV infection.
• CSF examination can be considered.
51. PREVENTION
PATIENT COUNSELING AND EDUCATION
• Nature of the disease
• Transmission
• Treatment and follow-up
• Risk reduction
MANAGEMENT OF SEX PARTNERS
• For sex partners of patients with syphilis in any stage
• Draw syphilis serology
• Perform physical exam
• For sex partners of patients with primary, secondary, or early latent syphilis
• Treat presumptively as for early syphilis at the time of examination, unless
• The nontreponemal test result is known and negative and
• The last sexual contact with the patient is > 90 days prior to examination.
52. SCREENING RECOMMENDATIONS
• Screen pregnant women at least at first prenatal visit.
• In high prevalence communities, or patients at risk
• Test twice during the third trimester, at 28 weeks, and at delivery, in addition to
routine early screening.
• Any woman who delivers a stillborn infant after 20 weeks gestation should
be tested for syphilis.
• Screen other populations based on local prevalence and the
patient’s risk behaviors.